Cosmetic and/or pharmaceutical compositions and their applications
Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
1. A method for regulating and/or stabilizing conditions affecting the skin of a subject in need thereof comprising:
administering to the subject a composition comprising from 65% to 93% of an aqueous-alcoholic extract of Allium species, from 5% to 33% of an aqueous-alcoholic extract of Citrus species, from 0.25% to 2.5% of an aqueous-alcoholic extract of Paullinia species, and from 0.25% to 2.5% of an aqueous-alcoholic extract of Theobroma species, wherein the conditions are selected from the group consisting of dermatoses, disorders of cicatrisation, disorders of keratinization, keratotic lesions, and hemorrhoidal pressure.
2. The method of claim 1 , wherein the dermatoses is selected from the group consisting of cutaneous bacterial or viral infections, ageing of the skin, bleaching or whitening of the skin, vitiligo, acrodermatitis, photodermatoses, acne, acne rosacea, lupus erythematosus, sensitive skin, insect stings, oily or dry skin, seborrheic disorders, alopecia, hair loss, psoriasis, parapsoriasis, dyshidrosis, warts, corns, scabies, angular cheilitis, and oedema.
3. The method of claim 1 , wherein the disorders of cicatrisation are selected from the group consisting of ciatrisation of wounds, including in subjects due to suffering from diabetes, burns, blotchiness, Behcet's disease, cutaneous porphyria, and angiomas.
4. The method of claim 1 , wherein the disorders of keratinsation are selected from the group consisting of keratotic lesions, hyperkeratosis, keratoderma, dyskeratosis, Darier's disease, parakeratosis, eczema, neurodermatitis, erythroderma, lichenification, scaly dermatosis, prurigo, keloid, and pustulosis.
5. The method of claim 1 , wherein the Allium species is Allium cepa , the Citrus species is Citrus lemon , the Paullinia species is Paullinia cupana , and the Theobroma species is Theobroma cacao.
6. A method for treating a condition affecting the skin, scalp, or external parts of a body of a subject in need thereof, the method comprising:
administering to the subject one to three times a day a composition comprising from 65% to 93% of an aqueous-alcoholic extract of Allium species, from 5% to 33% of an aqueous-alcoholic extract of Citrus species, from 0.25% to 2.5% of an aqueous-alcoholic extract of Paullinia species, and from 0.25% to 2.5% of an aqueous-alcoholic extract of Theobroma species; wherein the condition is selected from a group consisting of dermatosis due to cutaneous bacterial or viral infections, ageing of the skin, bleaching or whitening of the skin, vitiligo, acrodermatitis, photodermatosis, acne, acne rosacea, inflammatory acne, lupus erythematosus, sensitive skin, insect stings, oily or dry skin, seborrheic disorders, alopecia, hair loss, pityriasis capitis, pelada, sensitive scalp, greasy hair, psoriasis of the scalp, parapsoriasis of the scalp, dyshidrosis, warts, corns, scabies, angular cheilitis, oedema, nail disorders, disorders of cicatrisation, disorders of keratinization, keratotic lesions, burns, blotchiness, Behcet's disease, cutaneous porphyria, angiomas, hyperkeratosis, keratoderma, dyskeratosis, Darier's disease, parakeratosis, ichthyosis, eczema, neurodermatitis, erythroderma, lichenification, scaly dermatosis, prurigo, keloid, pustulosis, hemorrhoid pressure, and combinations thereof.
7. The method of claim 6 , wherein the Allium species is Allium cepa , the Citrus species is Citrus lemon , the Paullinia species is Paullinia cupana , and the Theobroma species is Theobroma cacao.
8. The method of claim 6 , wherein the composition is administered to the subject at a daily dose of about 5 to 500 mg.
9. The method of claim 6 , wherein the composition is administered to the subject at a daily dose of about 0.05 mg/kg to 10 mg/kg.